Novavax has made a smaller splash in the U.S. Covid-19 vaccine market than it had hoped. But it's betting on licensing deals ...

We continue to work closely with our partner to enable a seamless ... immunologic comparisons to establish non-inferiority ...

Novavax shares dropped Tuesday morning after the company slashed its full-year outlook when it announced its third-quarter results.

Novavax said the Food and Drug Administration allowed it to continue testing a combination COVID-19-flu and standalone flu vaccine that had been put on hold.

Besides Sanofi deal for nuvaxovid, Novavax has few opportunities to generate additional revenue, which likely means its stock ...

The mRNA vaccines work by prompting the body to temporarily make its own spike protein, which the immune system then responds ...

The U.S. Food and Drug Administration has lifted its clinical hold on a late-stage trial of Novavax's COVID-influenza and its standalone flu vaccines after a safety concern was found unrelated to the ...

(The Novavax vaccine works in a similar way to ... But he expects all of the vaccines to work. If someone has previously had a hard time with the expected side effects of the mRNA shots, such ...

Iris Patterson of Chicago Integrated Health in Matteson recommends residents get a COVID-19 vaccination as holidays approach.